RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Flexible design I was thinking the same thing about going private. I think we could do a better job running this company. I own more shares than most of the board members. I know many of you on this chat board do as well. I've been involved in financing requests larger than the Marathon deal, which is why I still cannot believe they violated two covenants in such a short amount of time. I've helped raise capital, albeit not in this space, but the communication skills of this company will not lend itself to further investment unless there are MAJOR changes. I'm extrememly disappointed they haven't managed their finances better. I cannot believe they haven't further shrunk the board and reduced executive salaries or at least changed the compensation structure. They waited too long to cut expenses and even longer to communicate it. The financial explanations are embarassing to say the least. It's like a novice analyst comparing year-over-year numbers without any real guidance other than top line revenue, which we've seen not only misses but changes. While maybe not a traditional approach, they need to separate the legacy drugs into it's own class so that investors can see exactly how profitable that is and what it would mean in terms of share value.
At this point, these guys have been such a colossal failure, I'd love to entertain putting a group together to go private. Or facilitate a sale to a more capable company in an all stock transaction valuing THTX at $15/share.